204 related articles for article (PubMed ID: 19426140)
1. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
2. [Identification of colorectal cancer using proteomic patterns in serum].
Zhao G; Gao CF; Song GY; Li DH; Wang XL
Ai Zheng; 2004 Jun; 23(6):614-8. PubMed ID: 15191657
[TBL] [Abstract][Full Text] [Related]
3. Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.
Becker S; Cazares LH; Watson P; Lynch H; Semmes OJ; Drake RR; Laronga C
Ann Surg Oncol; 2004 Oct; 11(10):907-14. PubMed ID: 15383419
[TBL] [Abstract][Full Text] [Related]
4. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.
Soltys SG; Le QT; Shi G; Tibshirani R; Giaccia AJ; Koong AC
Clin Cancer Res; 2004 Jul; 10(14):4806-12. PubMed ID: 15269156
[TBL] [Abstract][Full Text] [Related]
5. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
Seibert V; Ebert MP; Buschmann T
Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
[TBL] [Abstract][Full Text] [Related]
6. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
[TBL] [Abstract][Full Text] [Related]
7. Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer.
Kojima K; Asmellash S; Klug CA; Grizzle WE; Mobley JA; Christein JD
J Gastrointest Surg; 2008 Oct; 12(10):1683-90. PubMed ID: 18709425
[TBL] [Abstract][Full Text] [Related]
8. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry.
Koopmann J; Zhang Z; White N; Rosenzweig J; Fedarko N; Jagannath S; Canto MI; Yeo CJ; Chan DW; Goggins M
Clin Cancer Res; 2004 Feb; 10(3):860-8. PubMed ID: 14871961
[TBL] [Abstract][Full Text] [Related]
9. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.
Schwegler EE; Cazares L; Steel LF; Adam BL; Johnson DA; Semmes OJ; Block TM; Marrero JA; Drake RR
Hepatology; 2005 Mar; 41(3):634-42. PubMed ID: 15726646
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer.
Malik G; Ward MD; Gupta SK; Trosset MW; Grizzle WE; Adam BL; Diaz JI; Semmes OJ
Clin Cancer Res; 2005 Feb; 11(3):1073-85. PubMed ID: 15709174
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions.
Le L; Chi K; Tyldesley S; Flibotte S; Diamond DL; Kuzyk MA; Sadar MD
Clin Chem; 2005 Apr; 51(4):695-707. PubMed ID: 15695329
[TBL] [Abstract][Full Text] [Related]
12. Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population.
Chen YD; Zheng S; Yu JK; Hu X
Clin Cancer Res; 2004 Dec; 10(24):8380-5. PubMed ID: 15623616
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
Semmes OJ; Feng Z; Adam BL; Banez LL; Bigbee WL; Campos D; Cazares LH; Chan DW; Grizzle WE; Izbicka E; Kagan J; Malik G; McLerran D; Moul JW; Partin A; Prasanna P; Rosenzweig J; Sokoll LJ; Srivastava S; Srivastava S; Thompson I; Welsh MJ; White N; Winget M; Yasui Y; Zhang Z; Zhu L
Clin Chem; 2005 Jan; 51(1):102-12. PubMed ID: 15613711
[TBL] [Abstract][Full Text] [Related]
14. Serum CA 242: the search for a valid marker of pancreatic cancer.
Ventrucci M; Ubalducci GM; Cipolla A; Panella MA; Ligabue A
Clin Chem Lab Med; 1998 Mar; 36(3):179-84. PubMed ID: 9589807
[TBL] [Abstract][Full Text] [Related]
15. Molecular classification of liver cirrhosis in a rat model by proteomics and bioinformatics.
Xu XQ; Leow CK; Lu X; Zhang X; Liu JS; Wong WH; Asperger A; Deininger S; Eastwood Leung HC
Proteomics; 2004 Oct; 4(10):3235-45. PubMed ID: 15378689
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet.
Mitchell BL; Yasui Y; Lampe JW; Gafken PR; Lampe PD
Proteomics; 2005 May; 5(8):2238-46. PubMed ID: 15841498
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques.
Malyarenko DI; Cooke WE; Adam BL; Malik G; Chen H; Tracy ER; Trosset MW; Sasinowski M; Semmes OJ; Manos DM
Clin Chem; 2005 Jan; 51(1):65-74. PubMed ID: 15550476
[TBL] [Abstract][Full Text] [Related]
18. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.
Adam BL; Qu Y; Davis JW; Ward MD; Clements MA; Cazares LH; Semmes OJ; Schellhammer PF; Yasui Y; Feng Z; Wright GL
Cancer Res; 2002 Jul; 62(13):3609-14. PubMed ID: 12097261
[TBL] [Abstract][Full Text] [Related]
19. Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis.
Cadieux PA; Beiko DT; Watterson JD; Burton JP; Howard JC; Knudsen BE; Gan BS; McCormick JK; Chambers AF; Denstedt JD; Reid G
J Clin Lab Anal; 2004; 18(3):170-5. PubMed ID: 15103681
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic potential of serum proteomic patterns in prostate cancer.
Bañez LL; Prasanna P; Sun L; Ali A; Zou Z; Adam BL; McLeod DG; Moul JW; Srivastava S
J Urol; 2003 Aug; 170(2 Pt 1):442-6. PubMed ID: 12853795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
